1. Home
  2. ORC vs PHAR Comparison

ORC vs PHAR Comparison

Compare ORC & PHAR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Orchid Island Capital Inc.

ORC

Orchid Island Capital Inc.

HOLD

Current Price

$7.16

Market Cap

1.2B

Sector

Real Estate

ML Signal

HOLD

Logo Pharming Group N.V.

PHAR

Pharming Group N.V.

HOLD

Current Price

$17.87

Market Cap

1.1B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
ORC
PHAR
Founded
2010
1988
Country
United States
Netherlands
Employees
N/A
N/A
Industry
Real Estate Investment Trusts
Biotechnology: Pharmaceutical Preparations
Sector
Real Estate
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.2B
1.1B
IPO Year
2013
N/A

Fundamental Metrics

Financial Performance
Metric
ORC
PHAR
Price
$7.16
$17.87
Analyst Decision
Hold
Strong Buy
Analyst Count
2
3
Target Price
N/A
$30.00
AVG Volume (30 Days)
5.6M
20.3K
Earning Date
01-29-2026
11-06-2025
Dividend Yield
20.20%
N/A
EPS Growth
N/A
N/A
EPS
0.57
0.00
Revenue
$80,187,000.00
$362,274,000.00
Revenue This Year
$82.99
$24.80
Revenue Next Year
$61.79
$6.84
P/E Ratio
$12.43
$3,084.39
Revenue Growth
5.93
26.78
52 Week Low
$5.69
$7.50
52 Week High
$9.01
$18.12

Technical Indicators

Market Signals
Indicator
ORC
PHAR
Relative Strength Index (RSI) 44.24 60.83
Support Level $7.09 $15.76
Resistance Level $7.41 $17.35
Average True Range (ATR) 0.10 0.77
MACD -0.01 0.02
Stochastic Oscillator 21.78 89.41

Price Performance

Historical Comparison
ORC
PHAR

About ORC Orchid Island Capital Inc.

Orchid Island Capital Inc is a specialty finance company that invests in residential mortgage-backed securities. The principal and interest payments of its RMBS are guaranteed by the Federal National Mortgage Association, the Federal Home Loan Mortgage Corporation, or the Government National Mortgage Association, and are backed by single-family residential mortgage loans. The company's investment portfolio is divided into two categories namely traditional pass-through Agency RMBS; and structured Agency RMBS, such as collateralized mortgage obligations, interest-only securities, inverse interest-only securities, and principal-only securities, among other types of structured Agency RMBS.

About PHAR Pharming Group N.V.

Pharming Group is a biopharmaceutical company focused in transforming the lives of patients with rare, debilitating, and life-threatening diseases. The company is actively developing and commercializing a diverse portfolio of innovative treatments, including both biologics and small molecule therapies. Its commercial products are RUCONEST, approved for the treatment of acute attacks in adult and adolescent patients with hereditary angioedema, or HAE; and Joenja (leniolisib), a small-molecule kinase inhibitor, developed for the treatment of activated phosphoinositide 3-kinase delta syndrome.

Share on Social Networks: